Use App
  • AI Agent
  • Trending
  • News
  • Earnings
DIADIA0.87%
SPYSPY0.60%
QQQQQQ0.49%
Trending
Top trending tickerSHIBSHIB1.37%
XLFXLF0.92%
NEMNEM1.98%
CC1.22%
RTXRTX0.90%
ELFELF3.09%
BB2.68%
JNJJNJ1.93%
MSMS1.38%
SKYSKY0.02%

Feed

News

Sentiment

Earnings

Fundamentals

Info

homeSymbolINZY

INZY Inozyme Pharma Inc

About INZY

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company was founded by Axel Bolte, Joseph P. Schlessinger, and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA.
45

Neutral Sentiment

How do you feel about INZY?

Advertisement|Remove ads.

Latest INZY News

View
Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More
Zacks
BioMarin Offers to Buy Inozyme for $270M to Boost Enzyme Therapy Biz
Zacks
Inozyme Stock Rockets 179% After BioMarin Agrees To Acquire The Company For $270M: Retail Sentiment Brightens
Stocktwits
Loading...
Top Discussions
StocktwitsPollsStocktwitsPolls
What do you think the S&P 500's ($SPY) return will be next week?
12
44
4.9K votes
StocktwitsPollsStocktwitsPolls
A.I. stocks sold off after a report that OpenAI's annualized revenue is $20 billion lower than previously reported. What are you doing right now?
117
115
16.5K votes
StocktwitsPollsStocktwitsPolls
What do you think the S&P 500's ($SPY) return will be this week?
38
108
10.5K votes

Advertisement|Remove ads.

Advertisement|Remove ads.

Home
TrendingNews
Profile